메뉴 건너뛰기




Volumn 16, Issue 5, 2015, Pages 10715-10733

The multi-biomarker approach for heart failure in patients with hypertension

Author keywords

Biomarkers; Heart failure; Hypertension

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CARDIOTROPHIN 1; CYSTATIN C; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; EPLERENONE; GALECTIN 3; INTERLEUKIN 1 RECEPTOR TYPE I; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SPIRONOLACTONE; SYNDECAN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CYTOKINE; IL1R1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; PEPTIDE FRAGMENT; PREPRO-BRAIN NATRIURETIC PEPTIDE; PROCOLLAGEN; PROCOLLAGEN TYPE III-N-TERMINAL PEPTIDE; PROTEIN PRECURSOR; TUMOR NECROSIS FACTOR;

EID: 84929359012     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms160510715     Document Type: Article
Times cited : (31)

References (41)
  • 2
    • 79961165951 scopus 로고    scopus 로고
    • Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: Summary from the second international conference on pediatric cardiomyopathy
    • Kantor, P.F.; Rusconi, P.; Lipshultz, S.; Mital, S.; Wilkinson, J.D.; Burch, M. Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure: Summary from the second international conference on pediatric cardiomyopathy. Prog. Pediatr. Cardiol. 2011, 32, 11–14.
    • (2011) Prog. Pediatr. Cardiol , vol.32 , pp. 11-14
    • Kantor, P.F.1    Rusconi, P.2    Lipshultz, S.3    Mital, S.4    Wilkinson, J.D.5    Burch, M.6
  • 3
    • 43549099569 scopus 로고    scopus 로고
    • Biomarkers in heart failure. N
    • Braunwald, E. Biomarkers in heart failure. N. Engl. J. Med. 2008, 358, 2148–2159.
    • (2008) Engl. J. Med , vol.358 , pp. 2148-2159
    • Braunwald, E.1
  • 4
    • 12144290445 scopus 로고    scopus 로고
    • B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts: Fibrosis, myofibroblast conversion, proliferation, and inflammation
    • Kapoun, A.M.; Liang, F.; O’Young, G.; Damm, D.L.; Quon, D.; White, R.T.; Munson, K.; Lam, A.; Schreiner, G.F.; Protter, A.A. B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-β in primary human cardiac fibroblasts: Fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ. Res. 2004, 94, 453–461.
    • (2004) Circ. Res , vol.94 , pp. 453-461
    • Kapoun, A.M.1    Liang, F.2    O’Young, G.3    Damm, D.L.4    Quon, D.5    White, R.T.6    Munson, K.7    Lam, A.8    Schreiner, G.F.9    Protter, A.A.10
  • 6
    • 0034176934 scopus 로고    scopus 로고
    • Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
    • Troughton, R.W.; Frampton, C.M.; Yandle, T.G.; Espiner, E.A.; Nicholls, M.G.; Richards, A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000, 355, 1126–1130.
    • (2000) Lancet , vol.355 , pp. 1126-1130
    • Troughton, R.W.1    Frampton, C.M.2    Yandle, T.G.3    Espiner, E.A.4    Nicholls, M.G.5    Richards, A.M.6
  • 7
    • 0042198675 scopus 로고    scopus 로고
    • B-type natriuretic peptide in cardiovascular disease
    • De Lemos, J.A.; McGuire, D.K.; Drazner, M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 2003, 362, 316–322.
    • (2003) Lancet , vol.362 , pp. 316-322
    • De Lemos, J.A.1    McGuire, D.K.2    Drazner, M.H.3
  • 11
    • 84901271726 scopus 로고    scopus 로고
    • Effects of hypertension and exercise on cardiac proteome remodelling
    • 2014
    • Petriz, B.A.; Franco, O.L. Effects of hypertension and exercise on cardiac proteome remodelling. Biomed. Res. Int. 2014, 2014, 634132.
    • (2014) Biomed. Res. Int
    • Petriz, B.A.1    Franco, O.L.2
  • 12
    • 0142162082 scopus 로고    scopus 로고
    • Available online, (accessed on 8 August 2010)
    • NHS National Institute for Health and Care Excellence: Chronic Heart Failure: Management of Chronic Heart Failure in Adults in Primary and Secondary Care. Available online: http://www.nice.org.uk/guidance/cg108webcite (accessed on 8 August 2010).
    • Management of Chronic Heart Failure in Adults in Primary and Secondary Care
  • 13
    • 84864493727 scopus 로고    scopus 로고
    • ESC Committee for Practice Guidelines: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
    • McMurray, J.J.; Adamopoulos, S.; Anker, S.D.; Auricchio, A.; Bohm, M.; Dickstein, K.; Falk, V.; Filippatos, G.; Fonseca, C.; Gomez-Sanchez, M.A, et al. ESC Committee for Practice Guidelines: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2012, 33, 1787–1847.
    • (2012) Eur. Heart J , vol.33 , pp. 1787-1847
    • McMurray, J.J.1    Adamopoulos, S.2    Anker, S.D.3    Auricchio, A.4    Bohm, M.5    Dickstein, K.6    Falk, V.7    Filippatos, G.8    Fonseca, C.9    Gomez-Sanchez, M.A.10
  • 14
    • 0141925928 scopus 로고    scopus 로고
    • Sorting out the evidence on natriuretic peptides
    • McCullough, P.A.; Sandberg, K.R. Sorting out the evidence on natriuretic peptides. Rev. Cardiovasc. Med. 2003, 4, 13–19.
    • (2003) Rev. Cardiovasc. Med , vol.4 , pp. 13-19
    • McCullough, P.A.1    Sandberg, K.R.2
  • 15
    • 33645501811 scopus 로고    scopus 로고
    • Anemia in chronic kidney disease: Causes, diagnosis, treatment
    • Nurko, S. Anemia in chronic kidney disease: Causes, diagnosis, treatment. Clevel. Clin. J. Med. 2006, 73, 289–297.
    • (2006) Clevel. Clin. J. Med , vol.73 , pp. 289-297
    • Nurko, S.1
  • 16
    • 0042809588 scopus 로고    scopus 로고
    • N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease
    • James, S.K.; Lindahl, B.; Siegbahn, A.; Stridsberg, M.; Venge, P.; Armstrong, P.; Barnathan, E.S.; Califf, R.; Topol, E.J.; Simoons, M.L, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation 2003, 108, 275–281.
    • (2003) Circulation , vol.108 , pp. 275-281
    • James, S.K.1    Lindahl, B.2    Siegbahn, A.3    Stridsberg, M.4    Venge, P.5    Armstrong, P.6    Barnathan, E.S.7    Califf, R.8    Topol, E.J.9    Simoons, M.L.10
  • 18
    • 84871326314 scopus 로고    scopus 로고
    • Influencing factors for the plasma concentration of N-terminal brain natriuretic peptide precursor in patients with heart failure due to various heart diseases
    • Wei, B.Q.; Zhang, J.; Yang, Y.J.; Zhang, Y.H.; Huang, X.H.; Yu, L.T.; Zhou, Q.; Tan, H.Q.; Yang, Y.M.; Wang, G.G, et al. Influencing factors for the plasma concentration of N-terminal brain natriuretic peptide precursor in patients with heart failure due to various heart diseases. Zhonghua Yi Xue Za Zhi 2011, 91, 2683–2687.
    • (2011) Zhonghua Yi Xue Za Zhi , vol.91 , pp. 2683-2687
    • Wei, B.Q.1    Zhang, J.2    Yang, Y.J.3    Zhang, Y.H.4    Huang, X.H.5    Yu, L.T.6    Zhou, Q.7    Tan, H.Q.8    Yang, Y.M.9    Wang, G.G.10
  • 19
    • 31444448021 scopus 로고    scopus 로고
    • Controversies in ventricular remodelling
    • Opie, L.H.; Commerford, P.J.; Gersh, B.J. Controversies in ventricular remodelling. Lancet 2006, 367, 356–367.
    • (2006) Lancet , vol.367 , pp. 356-367
    • Opie, L.H.1    Commerford, P.J.2    Gersh, B.J.3
  • 21
    • 77954083241 scopus 로고    scopus 로고
    • Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target
    • Dobrev, D. Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmiedebergs Arch. Pharmacol. 2010, 381, 195–206.
    • (2010) Naunyn Schmiedebergs Arch. Pharmacol , vol.381 , pp. 195-206
    • Dobrev, D.1
  • 22
    • 0034881463 scopus 로고    scopus 로고
    • Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart
    • Ogawa, Y.; Tamura, N.; Chusho, H.; Nakao, K. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. Can. J. Physiol. Pharmacol. 2001, 79, 723–729.
    • (2001) Can. J. Physiol. Pharmacol , vol.79 , pp. 723-729
    • Ogawa, Y.1    Tamura, N.2    Chusho, H.3    Nakao, K.4
  • 23
    • 41149122223 scopus 로고    scopus 로고
    • Atrial natriuretic peptide inhibits transforming growth factor β-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts
    • Li, P.; Wang, D.; Lucas, J.; Oparil, S.; Xing, D.; Cao, X.; Novak, L.; Renfrow, M.B.; Chen, Y.F. Atrial natriuretic peptide inhibits transforming growth factor β-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ. Res. 2008, 102, 185–192.
    • (2008) Circ. Res , vol.102 , pp. 185-192
    • Li, P.1    Wang, D.2    Lucas, J.3    Oparil, S.4    Xing, D.5    Cao, X.6    Novak, L.7    Renfrow, M.B.8    Chen, Y.F.9
  • 25
    • 84894466867 scopus 로고    scopus 로고
    • Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure
    • López, B.; González, A.; Querejeta, R.; Larman, M.; Rábago, G.; Díez, J. Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure. Hypertension 2014, 63, 483–489.
    • (2014) Hypertension , vol.63 , pp. 483-489
    • López, B.1    González, A.2    Querejeta, R.3    Larman, M.4    Rábago, G.5    Díez, J.6
  • 26
    • 84884200646 scopus 로고    scopus 로고
    • Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients
    • Ravassa, S.; Beloqui, O.; Varo, N.; Barba, J.; López, B.; Beaumont, J.; Zalba, G.; Díez, J.; González, A. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients. J. Hypertens. 2013, 31, 587–594.
    • (2013) J. Hypertens , vol.31 , pp. 587-594
    • Ravassa, S.1    Beloqui, O.2    Varo, N.3    Barba, J.4    López, B.5    Beaumont, J.6    Zalba, G.7    Díez, J.8    González, A.9
  • 27
    • 84907963375 scopus 로고    scopus 로고
    • Plasma cardiotrophin-1 levels are associated with hypertensive heart disease: A meta-analysis
    • Song, K.; Wang, S.; Huang, B.; Luciano, A.; Srivastava, R.; Mani, A. Plasma cardiotrophin-1 levels are associated with hypertensive heart disease: A meta-analysis. J. Clin. Hypertens. 2014, 16, 686–692.
    • (2014) J. Clin. Hypertens , vol.16 , pp. 686-692
    • Song, K.1    Wang, S.2    Huang, B.3    Luciano, A.4    Srivastava, R.5    Mani, A.6
  • 28
    • 80054767576 scopus 로고    scopus 로고
    • As a marker of glomerular filtration rate: Prospects and limitations
    • Inker, L.A.; Okparavero, A. Cystatin C as a marker of glomerular filtration rate: Prospects and limitations. Curr. Opin. Nephrol. Hypertens. 2011, 20, 631–639.
    • (2011) Curr. Opin. Nephrol. Hypertens , vol.20 , pp. 631-639
    • Inker, L.A.1    Okparavero, A.2    Cystatin, C.3
  • 30
    • 82255192295 scopus 로고    scopus 로고
    • Levels are associated with the prognosis of systolic heart failure patients
    • Gao, C.; Zhong, L.; Gao, Y.; Li, X.; Zhang, M.; Wei, S. Cystatin C levels are associated with the prognosis of systolic heart failure patients. Arch. Cardiovasc. Dis. 2011, 104, 565–571.
    • (2011) Arch. Cardiovasc. Dis , vol.104 , pp. 565-571
    • Gao, C.1    Zhong, L.2    Gao, Y.3    Li, X.4    Zhang, M.5    Wei, S.6    Cystatin, C.7
  • 35
    • 0016998022 scopus 로고
    • Grading of angina pectoris
    • Campeau, L. Grading of angina pectoris. Circulation 1976, 54, 522–523.
    • (1976) Circulation , vol.54 , pp. 522-523
    • Campeau, L.1
  • 36
    • 0033574249 scopus 로고    scopus 로고
    • A more accurate accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
    • Modification of Diet in Renal Disease Study Group. A more accurate accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann. Intern. Med. 1999, 130, 461–470.
    • (1999) Ann. Intern. Med , vol.130 , pp. 461-470
  • 38
    • 38749137358 scopus 로고    scopus 로고
    • Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve
    • Cook, N.R. Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve. Clin. Chem. 2008, 54, 17–23.
    • (2008) Clin. Chem , vol.54 , pp. 17-23
    • Cook, N.R.1
  • 39
    • 79959716798 scopus 로고    scopus 로고
    • PredictABEL: An R package for the assessment of risk prediction models
    • Kundu, S.; Aulchenko, Y.S.; van Duijn, C.M.; Janssens, A.C.J.W. PredictABEL: An R package for the assessment of risk prediction models. Eur. J. Epidemiol. 2011, 26, 261–264.
    • (2011) Eur. J. Epidemiol , vol.26 , pp. 261-264
    • Kundu, S.1    Aulchenko, Y.S.2    Van Duijn, C.M.3    Janssens, A.4
  • 40
    • 38849091997 scopus 로고    scopus 로고
    • Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
    • Pencina, M.J.; D’Agostino, R.B., Sr.; D’Agostino, R.B., Jr.; Vasan, R.S. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat. Med. 2008, 27, 157–172.
    • (2008) Stat. Med , vol.27 , pp. 157-172
    • Pencina, M.J.1    D’Agostino, R.B.2    D’Agostino, R.B.3    Vasan, R.S.4
  • 41
    • 78649477601 scopus 로고    scopus 로고
    • Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
    • Pencina, M.J.; D’Agostino, R.B., Sr.; Steyerberg, E.W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat. Med. 2011, 30, 11–21.
    • (2011) Stat. Med , vol.30 , pp. 11-21
    • Pencina, M.J.1    D’Agostino, R.B.2    Steyerberg, E.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.